Learning the fundamentals of gene editing starts with understanding DNA, genes, and how the central dogma of molecular biology turns genetic information into proteins. This educational hub provides structured learning paths from absolute beginner through advanced topics, interactive visual explainers showing how CRISPR, base editing, and gene therapy work step by step, and a comprehensive glossary of every term you will encounter. Whether you are a student, a curious reader, or a professional transitioning into genomics, these resources will build your knowledge systematically.
Foundational concepts in molecular biology and genetics
Structured multi-article courses with quizzes and progress tracking
Interactive animated diagrams showing how gene editing tools work
Definitions of key terms across gene editing, therapy, and biotech
Accessible introductions to complex topics for newcomers
In-depth analysis and expert-level coverage
Approved gene therapies now cost between $2.1 million and $4.25 million per patient. This guide breaks down the real prices, why they are so high, how insurance and payment models are evolving, and why the global access crisis remains the field's most urgent unsolved problem.
A comprehensive, scientifically honest guide to BPC-157 — what the animal data actually shows, why zero human clinical trials have been completed, the legal gray zone in 2026, and what anyone considering this peptide needs to know.
Semaglutide and other GLP-1 receptor agonists are proving to be far more than weight-loss drugs. From cardiovascular protection and kidney disease to addiction, Alzheimer's, and sleep apnea, the expanding therapeutic reach of this peptide class is reshaping medicine.
A rigorous look at alpha-ketoglutarate (AKG) and Rejuvant — the mouse lifespan data, the 8-year biological age claim, and what's actually proven.
Intercellular communication aging explained: how hormonal, neural, and exosomal signaling break down with age — and why this hallmark is the most directly relevant to peptide therapy.
Anti-CRISPR proteins (Acrs) are bacteriophage-encoded off-switches for CRISPR. Discover how Acrs work and why they are becoming essential safety tools.
Autophagy longevity science explained: how the cell's recycling system declines with age and why it is a central target for healthspan interventions.
Bimagrumab plus GLP-1 is the leading strategy to preserve muscle during obesity drug treatment. Inside Lilly's $1.9B Versanis acquisition.
Blue zones longevity research is part genuine science, part storytelling. Here's what holds up under scrutiny — and what doesn't.
Bridge RNAs are the June 2024 gene editing breakthrough beyond CRISPR — a single enzyme that can insert, delete, or invert DNA precisely. A complete guide.
Caloric restriction longevity evidence reviewed: nearly a century of rodent, monkey, and human trials — and an honest assessment of what really works.
Cas12a (Cpf1) is the smaller, sharper alternative to Cas9 — single-RNA, sticky-end cuts, AT-rich PAM. Learn how Cas12 enzymes power both editing and diagnostics.
Cas13 RNA editing targets RNA instead of DNA — enabling reversible knockdown, programmable RNA edits, and the SHERLOCK diagnostics platform. A complete guide.
Inflammaging explained: how chronic low-grade inflammation drives aging, the role of NLRP3, SASP, IL-6, and the senolytic and anti-inflammatory drugs targeting it.
Compact CRISPR editors like CasX, CasMINI, CasΦ, and Cas-CLOVER solve the AAV packaging limit and unlock new in vivo therapies.
CRISPR activation (CRISPRa) turns endogenous genes on without inserting transgenes. Learn how dCas9-VP64, SAM, SunTag, and VPR work — and where CRISPRa is heading clinically.
CRISPR interference (CRISPRi) silences genes without cutting DNA. Learn how dCas9-KRAB works, its key papers, and why it is reshaping therapeutics.
Danuglipron was Pfizer's flagship oral GLP-1 bet for obesity. A look at what it was, why it failed, and what the discontinuation means.
Nutrient sensing aging explained: how insulin/IGF-1, mTOR, AMPK, and sirtuins drive longevity, and the rapamycin, metformin, and NAD+ evidence behind each pathway.
The 2026 state of epigenetic clocks — Horvath, Hannum, PhenoAge, GrimAge, DunedinPACE — how they're used in longevity trials and their real limits.
VO2 max longevity evidence is overwhelming. A rigorous look at the data: Cleveland Clinic, Kodama meta-analysis, zone 2, strength training, and dose.
FGF21 aging research shows a liver hormone that mimics fasting and extends mouse lifespan 40%. Here's the science, the trials, and the paradox.
Fisetin senolytic trial results reviewed: Mayo Clinic AFFIRM data, Kirkland's senolytic screen findings, and what 2026 human evidence actually supports so far.
GDF11 aging research sparked hope that a single blood factor could reverse aging — then collapsed into controversy. Here's what's real and what's not.
Genomic instability aging explained: DNA damage accumulation, progeroid syndromes, the ICE mouse, and the CRISPR base editors targeting progerin in clinical trials.
GlyNAC — glycine plus N-acetylcysteine — aims to restore glutathione in older adults. A rigorous look at the Baylor trials and what they actually show.
Irisin exercise research reveals how a muscle-released peptide drives brown fat activation, bone health, and even cognitive protection. The full story.
Klotho longevity science: Kuro-o's 1997 discovery, Dena Dubal's cognition work, kidney and brain roles, KL-VS variant, and the therapeutic pipeline in 2026.
An honest 2026 review of metformin anti-aging evidence — mechanism, UKPDS, TAME trial, exercise blunting, and who actually benefits.
Mitochondrial dysfunction aging explained: mtDNA mutations, ATP decline, MOTS-c, urolithin A, and the new CRISPR base editors that finally reach mitochondrial DNA.
Honest 2026 evidence review of NMN NAD precursors — do they raise NAD+, do they work, and what do the human trials actually show?
Parabiosis plasma dilution research reshaped longevity science. From young blood to saline swaps — the honest story of two decades of work.
Pemvidutide is Altimmune's balanced GLP-1/glucagon dual agonist peptide, posting 59% MASH resolution and 15.6% weight loss in Phase 2.
Proteostasis aging explained: how the heat shock response, ubiquitin-proteasome system, and autophagy fail with age — and which interventions actually restore protein quality control.
The honest 2026 evidence review for rapamycin longevity — mouse lifespan data, human trials (PEARL, TRIAD, dog trial), dosing, risks.
Retron gene editing uses bacterial reverse transcriptases to generate single-stranded DNA inside cells — a clever solution to prime editing's template delivery problem.
Updated senolytics clinical trials results for 2026: D+Q, fisetin, and UBX-1325 data analyzed. See which trials succeeded, which failed, and what comes next.
Spermidine longevity evidence review: polyamine biology, Madeo lab findings, mouse cardioprotection, human epidemiology, and what supplementation can actually do.
Stem cell exhaustion aging explained: how HSCs, satellite cells, and neural stem cells decline with age, and what parabiosis, Yamanaka reprogramming, and gene therapy can restore.
Taurine longevity explained — the Singh/Yadav 2023 Science paper, cross-species lifespan data, human correlations, and why one huge study is not replication.
Twin prime editing and PASTE extend prime editing to kilobase-scale insertions — using paired pegRNAs and serine integrases for full gene replacement.
Urolithin A mitophagy explained — how pomegranate metabolites and Mitopure target mitochondrial cleanup, the Andreux and Singh trials, and the 40% problem.
An in-depth look at how CRISPR components are delivered into cells, from viral vectors and lipid nanoparticles to electroporation and next-generation virus-like particles.
A deep dive into the ethical landscape of gene editing -- from the clear benefits of somatic therapy to the fraught territory of germline modification, designer babies, and the global governance gap.
Accessible introductions for newcomers
A head-to-head comparison of the three leading incretin-based therapies — semaglutide, tirzepatide, and retatrutide — covering mechanisms, weight loss data, side effects, cost, and who each one is best suited for.
Eli Lilly's retatrutide activates three metabolic receptors at once — GLP-1, GIP, and glucagon — producing up to 24.2% weight loss in Phase 2 trials. Here's how it works, how it compares to semaglutide and tirzepatide, and what to expect from Phase 3.
Novo Nordisk's oral Wegovy pill launched in January 2026, giving patients a needle-free path to GLP-1 weight loss. Here's how the 50 mg tablet stacks up against the weekly injection on efficacy, side effects, cost, and convenience.
CRISPR cuts DNA like molecular scissors. Epigenetic editing flips genes on or off like a dimmer switch — no cuts required. Here is how the two approaches compare in 2026, and why the future likely needs both.
What are senolytics? Do they actually work? Are they safe? A 2026 FAQ answering the most common questions about senolytic drugs and zombie cell clearance.
GLP-1 alcohol addiction evidence review: does Ozempic reduce drinking? Covers Leggio's NIAAA research, 2024 Molecular Psychiatry trial, and mechanism.
GLP-1 and Alzheimer's: complete 2026 evidence review covering EVOKE trials, liraglutide ELAD data, and whether semaglutide slows cognitive decline.
GLP-1 and kidney disease: the FLOW trial showed semaglutide cut major kidney events 24% in diabetic CKD. Full trial breakdown and clinical implications.
GLP-1 muscle loss explained: how much lean mass you lose on Ozempic, what STEP DEXA data shows, and evidence-based mitigation strategies.
Complete evidence-based guide to GLP-1 side effects from Ozempic, Wegovy, and Mounjaro — incidence rates, dose escalation strategy, and rare risks.
How does Ozempic work? A clear 2026 guide to GLP-1 drugs, the four mechanisms behind semaglutide, and how it compares to Mounjaro and Zepbound.
How long does Ozempic take to work? Appetite drops within days, steady-state in 4–5 weeks, peak weight loss at week 68. Full evidence timeline.
A beginner's guide to natural peptides in the body: insulin, oxytocin, glucagon, vasopressin, glutathione and how they shape therapeutic peptides.
Ozempic face explained: what causes it, why rapid weight loss affects facial appearance, and prevention strategies backed by dermatology evidence.
What is a peptide bond? A clear beginner's guide to amino acids, condensation reactions, and how peptide bonds shape every protein in your body.
A science-based beginner's guide to peptides for longevity — Epitalon, GHK-Cu, BPC-157, MOTS-c — honest evidence and the regulatory reality.
Peptides vs proteins: a clear explanation of size, structure, synthesis, and why the distinction matters for drug design and biology.
A clear beginner's guide to what peptides are, how the body makes them, and why peptide therapeutics are transforming medicine in 2026.
What happens when you stop Ozempic? Roughly two-thirds of weight lost returns within a year. Full trial data and strategies to maintain loss.
New to gene editing? This beginner-friendly guide explains what CRISPR is, how it works, and why it has become the most important biotechnology tool of the 21st century.
The 12 hallmarks of aging provide a scientific framework for understanding why we age and where interventions might slow or reverse the process.
Telomeres — the protective caps on your chromosomes — shorten with every cell division, acting as a biological countdown clock that shapes aging, cancer, and the limits of cellular life.
A comprehensive introduction to CRISPR-Cas9 gene editing, covering its discovery, molecular mechanism, real-world applications, and the ethical questions it raises.
An accessible introduction to synthetic biology — the field that applies engineering principles to living systems, with applications ranging from biofuels to programmable medicines.
Your birthday tells you your chronological age. Epigenetic clocks reveal your biological age — and why the difference matters for longevity science.
DNA makes RNA. RNA makes protein. This simple rule — the Central Dogma — is the foundation of all molecular biology and the reason gene editing works.
DNA stores your genetic blueprint. RNA carries it out. Understanding this difference is the key to understanding everything from CRISPR to mRNA vaccines.
A beginner's guide to gene therapy — how it delivers genetic fixes into cells, the different approaches, and why it's transforming medicine.
A gene is a section of DNA that contains the instructions for building one protein. You have about 20,000 of them, and they make you you. Here's everything you need to know.
How your cells read DNA instructions and build proteins — the process that gene editing ultimately aims to control.
A beginner-friendly guide to DNA — what it is, how it stores genetic information, and why it matters for gene editing.
The building blocks of proteins. Twenty standard amino acids are encoded by DNA and assembled in specific sequences to create proteins. A single-base mutation can change one amino acid, sometimes causing disease.
The complex of DNA and histone proteins that makes up chromosomes. Chromatin can be 'open' (euchromatin, genes accessible) or 'closed' (heterochromatin, genes silenced), controlling gene expression.
A three-nucleotide sequence in mRNA that specifies a particular amino acid (or a stop signal) during protein synthesis. The 64 possible codons map to 20 amino acids, creating redundancy in the genetic code.
Deoxyribonucleic acid — the molecule that carries genetic instructions in all living organisms. Made of two strands twisted into a double helix, with bases A, T, C, and G.
A regulatory DNA sequence that can increase transcription of a gene, sometimes from a great distance (thousands of base pairs away). Enhancers are key targets for epigenetic editing approaches.
The complete set of chemical modifications on DNA and histone proteins that regulate gene expression without changing the underlying DNA sequence. The epigenome changes with age and is a target for longevity research.
A segment of a gene that codes for protein. After transcription, exons are spliced together to form the messenger RNA (mRNA) that is translated into protein. Many gene therapies target specific exons — for example, exon skipping in Duchenne muscular dystrophy.
A form of hemoglobin (HbF) naturally produced during fetal development but largely silenced after birth. Reactivating fetal hemoglobin via CRISPR editing of BCL11A is the mechanism behind Casgevy's treatment for sickle cell disease.
A segment of DNA that contains instructions for making a specific protein or RNA molecule. Humans have approximately 20,000 protein-coding genes.
The process by which information encoded in a gene is used to produce a functional protein or RNA molecule. Involves transcription (DNA to mRNA) and translation (mRNA to protein). Gene editing can modify expression levels.
The complete set of DNA in an organism, including all genes and non-coding regions. The human genome contains about 3 billion base pairs.
The protein in red blood cells that carries oxygen throughout the body. Mutations in hemoglobin genes cause sickle cell disease and beta-thalassemia.
Proteins around which DNA is wound to form chromatin. Chemical modifications to histones (acetylation, methylation) control how tightly DNA is packed, regulating which genes are accessible for transcription.
A non-coding segment of a gene that is transcribed into RNA but spliced out before translation. Introns were once considered 'junk DNA' but play important roles in gene regulation and alternative splicing.
The addition of a methyl group (CH3) to DNA, typically at cytosine bases. DNA methylation generally silences gene expression and changes predictably with age, forming the basis of epigenetic clocks.